What's more, PTPN22 exhibits overexpression in CLL and positively regulates the antiapoptotic AKT kinase, which provides a powerful survival signal to antigen-stimulated CLL cells [8]. The gene discussed is PTPN22; the disease is B-cell chronic lymphocytic leukemia.